BACKGROUND: Surveillance mammography for breast cancer survivors can detect recurrences early when treatment is most effective. We assessed the receipt of surveillance mammography for elderly breast cancer survivors considering their Medicaid and Medicare dual eligibility and minority status that may make them vulnerable to poor surveillance care. METHODS: We analyzed Michigan Medicare and Medicaid data for patients, age 66 years or older, diagnosed with early stage breast cancer between 1997 and 2000. Using logistic regression and proportional hazards models, we identified individual and area level factors associated with patients' receipt and timeliness of surveillance mammography for up to 3 years post treatment. RESULTS: In the first year post cancer treatment, patients who received breast conserving surgery (BCS) and radiation therapy were more likely to receive surveillance mammography than those treated with BCS alone (OR = 1.82; 95% CI = 1.48-2.24). Patients who received BCS and radiation treatment also had a greater probability of receiving surveillance mammography sooner than those treated with BCS alone (HR = 1.72; 95% CI = 1.56-1.89). Time from treatment to mammography was longer for older (80+ years) versus younger patients (HR = 0.55; 95% CI = 0.45-0.66) and for those with greater comorbidity burden (HR = 0.59; 95% CI = 0.43-0.81). CONCLUSIONS: Regardless of race and dual eligibility, there is a greater likelihood for breast cancer patients who received BCS with radiation to receive surveillance mammography and to receive it sooner than for patients who were treated with BCS alone. IMPLICATIONS FOR CANCER SURVIVORS: Dual eligible, black, and elderly patients are less likely to receive radiation following BCS, thus disparities across the treatment and surveillance continuum need to be further investigated.
BACKGROUND: Surveillance mammography for breast cancer survivors can detect recurrences early when treatment is most effective. We assessed the receipt of surveillance mammography for elderly breast cancer survivors considering their Medicaid and Medicare dual eligibility and minority status that may make them vulnerable to poor surveillance care. METHODS: We analyzed Michigan Medicare and Medicaid data for patients, age 66 years or older, diagnosed with early stage breast cancer between 1997 and 2000. Using logistic regression and proportional hazards models, we identified individual and area level factors associated with patients' receipt and timeliness of surveillance mammography for up to 3 years post treatment. RESULTS: In the first year post cancer treatment, patients who received breast conserving surgery (BCS) and radiation therapy were more likely to receive surveillance mammography than those treated with BCS alone (OR = 1.82; 95% CI = 1.48-2.24). Patients who received BCS and radiation treatment also had a greater probability of receiving surveillance mammography sooner than those treated with BCS alone (HR = 1.72; 95% CI = 1.56-1.89). Time from treatment to mammography was longer for older (80+ years) versus younger patients (HR = 0.55; 95% CI = 0.45-0.66) and for those with greater comorbidity burden (HR = 0.59; 95% CI = 0.43-0.81). CONCLUSIONS: Regardless of race and dual eligibility, there is a greater likelihood for breast cancerpatients who received BCS with radiation to receive surveillance mammography and to receive it sooner than for patients who were treated with BCS alone. IMPLICATIONS FOR CANCER SURVIVORS: Dual eligible, black, and elderly patients are less likely to receive radiation following BCS, thus disparities across the treatment and surveillance continuum need to be further investigated.
Authors: Chyke A Doubeni; Terry S Field; Marianne Ulcickas Yood; Sharon J Rolnick; Charles P Quessenberry; Hassan Fouayzi; Jerry H Gurwitz; Feifei Wei Journal: Cancer Date: 2006-06-01 Impact factor: 6.860
Authors: James L Khatcheressian; Antonio C Wolff; Thomas J Smith; Eva Grunfeld; Hyman B Muss; Victor G Vogel; Francine Halberg; Mark R Somerfield; Nancy E Davidson Journal: J Clin Oncol Date: 2006-10-10 Impact factor: 44.544
Authors: Nancy L Keating; Mary Beth Landrum; Edward Guadagnoli; Eric P Winer; John Z Ayanian Journal: J Clin Oncol Date: 2006-01-01 Impact factor: 44.544
Authors: Lisa M Lines; Julia Cohen; Michael T Halpern; Ashley Wilder Smith; Erin E Kent Journal: Cancer Causes Control Date: 2019-08-17 Impact factor: 2.506
Authors: Jasmin A Tiro; Joanne M Sanders; L Aubree Shay; Caitlin C Murphy; Heidi A Hamann; L Kay Bartholomew; Lara S Savas; Sally W Vernon Journal: Breast Cancer Res Treat Date: 2015-04-29 Impact factor: 4.872
Authors: Pragati S Advani; Jun Ying; Richard Theriault; Amal Melhem-Bertrand; Stacy Moulder; Isabelle Bedrosian; Welela Tereffe; Shon Black; Tunghi May Pini; Abenaa M Brewster Journal: Cancer Date: 2013-11-20 Impact factor: 6.860
Authors: Melissa Y Carpentier; Jasmin A Tiro; Lara S Savas; L Kay Bartholomew; Trisha V Melhado; Sharon P Coan; Keith E Argenbright; Sally W Vernon Journal: J Cancer Surviv Date: 2012-12-18 Impact factor: 4.442
Authors: Laurel Clayton Trantham; Matthew E Nielsen; Lee R Mobley; Stephanie B Wheeler; William R Carpenter; Andrea K Biddle Journal: Cancer Date: 2013-07-24 Impact factor: 6.860
Authors: Lindsey Enewold; Katherine A McGlynn; Shelia H Zahm; Ismail Jatoi; William F Anderson; Abegail A Gill; Craig D Shriver; Kangmin Zhu Journal: Cancer Date: 2013-08-01 Impact factor: 6.860
Authors: Andy S L Tan; Mihaela Moldovan-Johnson; Stacy W Gray; Robert C Hornik; Katrina Armstrong Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-11-01 Impact factor: 4.254
Authors: Mehdi Boukhechba; Sonia Baee; Alicia L Nobles; Jiaqi Gong; Kristen Wells; Laura E Barnes Journal: IEEE EMBS Int Conf Biomed Health Inform Date: 2018-04-09